|
|
|
Substance Name: Trifluridine [USAN:USP:INN]
RN: 70-00-8
UNII: RMW9V5RW38
InChIKey: VSQQQLOSPVPRAZ-RRKCRQDMSA-N
Note
- An antiviral derivative of THYMIDINE used mainly in the treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to HERPES SIMPLEX virus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p557)
Molecular Formula
- C10-H11-F3-N2-O5
Molecular Weight
- 296.1999
- All
- Classifications
- Links to Resources
- Names & Synonyms
- Registry Numbers
- Structure Descriptors
- Toxicity
- Physical Properties
Classification Codes
- Anti-Infective Agents
- Antimetabolites
- Antiviral (Ophthalmic)
- Antiviral Agents
- Mutation Data
- Noxae
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Trifluridine
- Trifluridine [USAN:USP:INN]
MeSH Heading
- Trifluridine
Synonyms
- 2'-Deoxy-5-(trifluoromethyl)uridine
- 2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-beta-D-ribofuranosyl)-5-(trifluoromethyl)-
- 5-(Trifluoromethyl)deoxyuridine
- 5-Trifluoro-2'-deoxythymidine
- 5-Trifluoromethyl-2-deoxyuridine
- BRN 0568095
- CCRIS 2348
- EINECS 200-722-8
- F3DThd
- F3T
- F3TDR
- HSDB 8126
- NSC 529182
- NSC 75520
- TFDU
- Trifluoromethyldeoxyuridine
- Trifluorothymidine
- Trifluridina
- Trifluridina [INN-Spanish]
- Trifluridine
- Trifluridinum
- Trifluridinum [INN-Latin]
- UNII-RMW9V5RW38
- Uridine, 2'-deoxy-5-(trifluoromethyl)-
- Viroptic
Systematic Names
- 5-Trifluorothymidine
- Thymidine, alpha,alpha,alpha-trifluoro-
- Trifluridine
Registry Numbers
CAS Registry Number
- 70-00-8
FDA UNII
- RMW9V5RW38
System Generated Number
- 0000070008
Structure Descriptors
InChI
1S/C10H11F3N2O5/c11-10(12,13)4-2-15(9(19)14-8(4)18)7-1-5(17)6(3-16)20-7/h2,5-7,16-17H,1,3H2,(H,14,18,19)/t5-,6+,7+/m0/s1InChIKey
VSQQQLOSPVPRAZ-RRKCRQDMSA-NSmiles
c1c(c(=O)Toxicity
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| monkey | LDLo | intravenous | 400mg/kg (400mg/kg) | Government Reports Announcements. Vol. 74(9), Pg. 60, 1974. | |
| mouse | LD50 | intraperitoneal | 1931mg/kg (1931mg/kg) | National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986, | |
| mouse | LD50 | intravenous | 3381mg/kg (3381mg/kg) | Progress Report Submitted to the National Cancer Institute by Arthur D. Little, Inc. Vol. -, Pg. 260, 1967. | |
| rat | LD50 | intravenous | 2946mg/kg (2946mg/kg) | LIVER: OTHER CHANGES | Progress Report Submitted to the National Cancer Institute by Arthur D. Little, Inc. Vol. -, Pg. 260, 1967. |
Physical Properties
| Physical Property | Value | Units | Temp (deg C) | Source |
|---|---|---|---|---|
| Melting Point | 186-189 | deg C | EXP | |
| pKa Dissociation Constant | 7.95 | (none) | EXP | |
| log P (octanol-water) | -0.46 | (none) | EXP | |
| Water Solubility | 1560 | mg/L | 25 | EST |
| Vapor Pressure | 9.27E-14 | mm Hg | 25 | EST |
| Henry's Law Constant | 9.53E-17 | atm-m3/mole | 25 | EST |
| Atmospheric OH Rate Constant | 7.53E-11 | cm3/molecule-sec | 25 | EST |
Physical property data is provided to ChemIDplus by SRC, Inc.